Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3451-3456

  Sargent, Linda M ^b   Dragan, Yvonne P ^a   Sattler, Gerald ^a   Xu, Yi Hua ^a   Wiley, John ^c   Pilot, Henry C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS T ANTIGEN;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 15; CHROMOSOME 1Q; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME LOSS; CONTROLLED STUDY; ENHANCER REGION; FEMALE; KARYOTYPE; KARYOTYPING; LIVER CARCINOGENESIS; LIVER CELL; MALIGNANT TRANSFORMATION; METAPHASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIMIAN VIRUS 40; TRANSGENE; TRANSGENIC MOUSE; TRISOMY; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; FEMALE; KARYOTYPING; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030761976     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pitot, H. C., and Dragan, Y. P. Chemical induction of neoplasia. In: I. Arias, J. Boyer, N. Fausto, W. Jakoby, and D. Schater (eds.), The Liver; Biology and Pathobiology, ed. 3., pp. 1467-1498. New York: Raven Press, Ltd., 1994.
2. Adams, J., and Cory, S. Transgenic models of tumor development. Science (Washington DC), 254: 1161-1166, 1991.
3. Hanahan, D. Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet., 22: 479-519, 1988.
4. Merlino, G. Transgenic mice: designing genes for molecular models. In: I. Arias, J. Boyer, N. Fausto, W. Jakoby, and D. Schater (eds.), The Liver: Biology and Pathobiology, ed. 3, pp. 1579-1590. New York: Raven Press Ltd., 1994.
5. Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D., and Brinster, R. L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene, 4: 715-724, 1989.
6. Jhappan, Ch., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merlino, G. T. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61: 1137-1146, 1990.
7. Sandgren, E. P., Luetteke, N. C., Qiu, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D. C. Transforming growth factor α dramatically enhances oncogene induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol., 13: 320-330, 1993.
8. Murakami, H., Sanderson, N., Nagy, P., Marino, P., Merlino, G. T., and Thorgeirsson, S. S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis-interaction of c-myc expression in an IL-3 dependent in myeloid cell line suppresses cell cycle and accelerates apoptosis. Oncogene, 6: 1915-1922, 1991.
9. Hulley, J. R., Lohse, J. K., Griep, A. E., Sattler, C. A., Haas, M. J., Dragan, Y., Neveu, M., and Pitot, H. C. Transgenic hepatocarcinogenesis in the rat. Am. J. Pathol., 145: 386-397, 1994.
10. Yeh, S., Chen P-J., Lai, M-Y., Wang, C-C., and Chen, D-S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res., 54: 4188-4192, 1994.
11. Wang, H. P., and Rogler, C. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48: 72-78, 1988.
12. Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V., Brechot, C., Redeker, A., and Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Genetics, 86: 8852-8856, 1989.
13. Tsuda, H., Zhang, W., and Shimasato, Y. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 6791-6794, 1990.
14. Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res., 52: 5368-5372, 1992.
15. Zhang, W., Hirohashi, S., Tsuda, H., Shimasato, Y., Yokata, J., Terada, M., and Sugimura, T. Frequent loss of heterozygosity on chromosome 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res., 81: 108-111, 1990.
16. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Yagura, M., Matsuhara, K., and Nakamura, Y. Allelotype of study of primary hepatocellular carcinoma. Cancer Res., 51: 89-93, 1991.
17. Walker, G. J., Hayward, N. K., Falvery, S., and Cooksley, W. G. E. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51: 4367-4370, 1991.
18. Emi, M., Fujiwara, Y., Ohata, H., Tsuda, H., Hirohashi, S., Koike, M., Miyaki, M., Monden, M., and Nakamura, Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes & Cancer, 7: 152-157, 1993.
19. Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., and Thorgeirsson, S. S. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54: 281-285, 1994.
20. Sargent, L. M., Xu, Y-H., Sattler, G. L., and Pitot, H. C. Ploidy and karyotype of enzyme altered foci isolated from two separate models of hepatocarcinogenesis in the rat. Carcinogenesis (Lond.), 10: 387-391, 1989.
21. Sargent, L. M., Sattler, G. L., Roloff, B., Xu, Y-H., Sattler, C. A., Meisner, L., and Pitot, H. C. Ploidy, and Specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res., 52: 955-962, 1992.
22. Sargent, L. M., Dragan, Y. P., Xu, Y-H., Sattler, G., Wiley, J. E., and Pitot, H. C. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res., 56: 2985-2991, 1996.
23. Sargent, L. M., Dragan, Y. P., Babcock, K., Wiley, J. E., Haas, M. J., Klaunig, J. E., Sattler, G., Sattler, C., and Pitot, H. C. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WbrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. Cancer Res., 56: 2992-2997, 1996.
24. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 18: 159-170, 1996.
25. Rowley, J. Chromosome abnormalities in cancer. Cancer Genet. Cytogenet., 2: 175-198, 1980.
26. Cullen, J. M., Sandgren, E. P., Brinster, R. L., and Maronpol, R. R. Histologic characterization of hepatic carcinogenesis in transgenic mice expression SV40 T-antigens. Vet. Pathol., 30: 111-118, 1993.
27. Xu, Y-H., Sattler, G. L., and Pitot, H. C. A method for the comparative study of replicative DNA synthesis in GGT-positive and GGT-negative hepatocytes in primary culture isolated from carcinogen-treated rats. In Vitro (Rockville), 24: 995-1000, 1988.
28. Kreamer, B. L., Staecker, J. L., Sawada, N., Sattler, G. L., Hsia, M. T., and Pitot, H. C. Use of a low-speed isodensity Percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro Cell & Dev. Biol., 22: 210-211, 1986.
29. James, J. The genesis of polyploidy in rat liver parenchymal cells. Eur. J. Cell Biol., 15: 410-419, 1977.
30. De Feijter, A. W., Ray, J. S., Weghorst, C. M., Klaunig, J. E., Goodman, J. I., Chang, C. C., Ruch, R. J., and Trosko, J. E. Infection of rat liver epithelial cells with v-Ha-ras: correlation between oncogene expression, gap junctional communication, and tumorigenicity. Mol. Carcinog., 3: 54-67, 1990.
31. Colemun, W., McCullough, K., Esch, G., Civalier, C., Livanos, E., Weissman, B., Grisham, J., and Smith, G. Suppression of the tumorigenic phenotype of a rat liver epithelial cell line by the p11.2p-12 region of human chromosome 11. Mol. Carcinog., 13: 220-232, 1995.
32. Copeland, N. G., Jenkins, N. A., Gilbert, D. J., and Eppig, J. T. A genetic linkage map of the mouse, current applications and future prospects. Science (Washington DC), 262: 57-66, 1993.
33. Widmer, U., Schmid, C., Zapf, J., and Froesch, E. R. Effects of insulin like growth factor II on chick embryo hepatocytes. Acta Endocrinol., 108: 237-244, 1985.
34. Yang, D., and Rogler, C. E. Analysis of insulin-like growth factor II (IGFI expression in neoplastic nodules and hepatocellular carcinoma of woodchucks utilizing in situ hybridization and immunohistochemistry. Carcinogenesis (Lond.), 12: 1893-1901, 1991.
35. Christofori, G., Naik, P., and Hanahan, D. A. A second signal supplied by insulin-like growth factor II in oncogene induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
36. Cariani, B., Lasserre, C., Kemeny, F., Franco, D., and Brechot, C. Expression of insulin-like growth factor II, α-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Hepatology, 13: 644-649, 1991.
37. Daughaday, W. H., Wu, J. C., Lee, S. D., and Kapadia, M. Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus transcripts in human primary liver cancer. J. Lab. Clin. Med., 116: 555-562, 1990.
38. Shirmacker, A., Held, W. A., Yang, D., Chisari, F. V., Rustum, Y., and Rogler, C. E. Reactivation of insulin-like-growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res., 52: 2549-2556, 1992.
39. Held, W. A., pazik, J., Giancola, J., O'Brien, G., Kerns, K., Gobey, M., Mels, R., Kenny, L., and Rustum, Y. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54: 6489-6495, 1994.
40. Ishikawa, T., Kyprianou, N., and Issacs, J. T. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. Cancer Res., 50: 6349-6357, 1990.
41. Gallahan, L. S., Chen, A., and Aldaz, C. M. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol. Carcinog., 12: 7-13, 1995.
42. Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Gray, J., Bradley, A., Medina, D., and Varmus, H. E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev., 9: 882-895, 1995.
43. Li, X., Adam, G., Cui, H., Sandstedt, B., Ohlsson, R., and Ekstrom, T. J. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human. Oncogene, 11: 221-229, 1995.
44. Rainier, S., Dobry, C. J., and Feinberg, A. P. Loss of imprinting in hepatoblastoma. Cancer Res., 55: 1836-1838, 1995.
45. Montagna, M., Menin, C., Chieco-Bianchi, L., and D'Andrea, H. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J. Cancer Res. Clin. Oncol., 120(12): 732-736, 1994.
46. Byrne, J. A., and Smith, P. J. The 11p15.5 ribonucleotide reductase M1 subunit locus is not imprinted in Wilms' tumor and hepatoblastoma. Hum. Genet., 91: 275-277, 1993.
47. Weissman, B. E., Saxon, P. J., Pasquale, S. R., Jones, G. R., Geiser, A. G., and Standbridge, E. J. Introduction of a normal human chromosome 11 into Wilms' tumor cell line controls its tumorigenic expression. Science (Washington DC). 236: 175-180, 1987.
48. Kovi, E., and Morris, H. P. Chromosome banding studies of several transplanlable hepatomas. Adv. Enzyme Regul., 14: 139-162, 1983.
49. Stedman, J. S., Lee, L. W., Smith, G. J., and Grisham, J. W. DNA contents and chromosomes of clonal lines of transformed rat liver epithelial cells of cells from the derived tumors. Carcinogenesis (Lond.), 15: 963-969, 1994.
50. Albrecht, S., von Schweinitz, D., Waha, A., Kraus, J. A., Vondeimling, A., and Pietsch, T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res., 54: 5041-5044, 1994.
51. Klinger, H. P., and Shows, T. B. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells, J. Natl. Cancer Inst., 71: 559-569, 1983.
52. Levan, G., Szpirer, J., Szpirer, C., Klinga, K., Hanson, C., and Islam, M. Q. The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics, 10: 699-718, 1991.
53. Gariboldi, M., Manenti, G., Canaan, F., Falvella, F. S., Pierotti, M. A., Porta, G. D., Binelli, G., and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver Carcinogenesis. Cancer Res., 53: 209-211, 1993.
54. Davis, L. M., Daspary, W. J., Sakallah, S. E., Maronpot, R., Wiseman, R., Varrett, J. C., Elliott, R., and Hozier, J. C. Loss of heterozygosity in spontaneous and chemically-induced tumors of the B6C3F1 mouse. Carcinogenesis (Lond.), 15: 1637-1645, 1994.